These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22034035)

  • 21. Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies.
    Huttner NA; Girod A; Perabo L; Edbauer D; Kleinschmidt JA; Büning H; Hallek M
    Gene Ther; 2003 Dec; 10(26):2139-47. PubMed ID: 14625569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.
    Muzyczka N; Warrington KH
    Hum Gene Ther; 2005 Apr; 16(4):408-16. PubMed ID: 15871672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adeno-associated viral vectors and their redirection to cell-type specific receptors.
    Michelfelder S; Trepel M
    Adv Genet; 2009; 67():29-60. PubMed ID: 19914449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altering AAV tropism with mosaic viral capsids.
    Gigout L; Rebollo P; Clement N; Warrington KH; Muzyczka N; Linden RM; Weber T
    Mol Ther; 2005 Jun; 11(6):856-65. PubMed ID: 15922956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
    Zaiss AK; Muruve DA
    Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the fate of rAAV genomes following in vivo administration.
    Clark KR; Penaud-Budloo M
    Methods Mol Biol; 2011; 807():239-58. PubMed ID: 22034033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stable transduction of large DNA by high-capacity adeno-associated virus/adenovirus hybrid vectors.
    Gonçalves MA; van der Velde I; Knaän-Shanzer S; Valerio D; de Vries AA
    Virology; 2004 Apr; 321(2):287-96. PubMed ID: 15051388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.
    Clark KR; Voulgaropoulou F; Johnson PR
    Gene Ther; 1996 Dec; 3(12):1124-32. PubMed ID: 8986439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus Vectors.
    Lam AK; Frabutt D; Li L; Xiao W
    Hum Gene Ther; 2021 Dec; 32(23-24):1433-1438. PubMed ID: 34254844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of recombinant adeno-associated virus vector containing the rat preproinsulin II gene.
    Peng L; Sidner RA; Bochan MR; Burton MM; Cooper ST; Jindal RM
    J Surg Res; 1997 Apr; 69(1):193-8. PubMed ID: 9202669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids.
    Grifman M; Trepel M; Speece P; Gilbert LB; Arap W; Pasqualini R; Weitzman MD
    Mol Ther; 2001 Jun; 3(6):964-75. PubMed ID: 11407911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive delivery.
    Liqun Wang R; McLaughlin T; Cossette T; Tang Q; Foust K; Campbell-Thompson M; Martino A; Cruz P; Loiler S; Mueller C; Flotte TR
    Mol Ther; 2009 Jan; 17(1):81-7. PubMed ID: 18941444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.
    Castle MJ; Turunen HT; Vandenberghe LH; Wolfe JH
    Methods Mol Biol; 2016; 1382():133-49. PubMed ID: 26611584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. rAAV Engineering for Capsid-Protein Enzyme Insertions and Mosaicism Reveals Resilience to Mutational, Structural and Thermal Perturbations.
    Feiner RC; Teschner J; Teschner KE; Radukic MT; Baumann T; Hagen S; Hannappel Y; Biere N; Anselmetti D; Arndt KM; Müller KM
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy.
    Liu Y; Siriwon N; Rohrs JA; Wang P
    Curr Pharm Des; 2015; 21(22):3248-56. PubMed ID: 26027561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands.
    Ponnazhagan S; Mahendra G; Kumar S; Thompson JA; Castillas M
    J Virol; 2002 Dec; 76(24):12900-7. PubMed ID: 12438615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adeno-associated virus capsid protein expression in Escherichia coli and chemically defined capsid assembly.
    Le DT; Radukic MT; Müller KM
    Sci Rep; 2019 Dec; 9(1):18631. PubMed ID: 31819093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of adeno-associated virus particles and empty capsids by optical density measurement.
    Sommer JM; Smith PH; Parthasarathy S; Isaacs J; Vijay S; Kieran J; Powell SK; McClelland A; Wright JF
    Mol Ther; 2003 Jan; 7(1):122-8. PubMed ID: 12573625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next-generation AAV vectors for clinical use: an ever-accelerating race.
    Weinmann J; Grimm D
    Virus Genes; 2017 Oct; 53(5):707-713. PubMed ID: 28762205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing the adeno-associated viral vector system: a brief summary.
    Hacker U; Büning H
    Ther Deliv; 2011 Aug; 2(8):967-70. PubMed ID: 22826865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.